Variant report

Variant	rs3743231
Chromosome Location	chr15:31283136-31283137
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:31281475..31285433-chr15:31293926..31297603,3	K562	blood:
2	chr15:31283081..31284688-chr22:29195568..29197954,2	MCF-7	breast:
3	chr15:31194360..31196709-chr15:31282391..31284386,2	MCF-7	breast:
4	chr15:31282575..31285514-chr15:31322559..31324126,2	MCF-7	breast:
5	chr15:31281226..31284928-chr15:31292691..31294333,3	MCF-7	breast:
6	chr15:31283135..31283746-chr6:134495837..134496431,2	Hela-S3	cervix:
7	chr15:31283072..31283773-chr17:29151257..29151810,2	Hela-S3	cervix:
8	chr15:31218794..31220951-chr15:31282389..31284227,2	K562	blood:
9	chr15:31195772..31198184-chr15:31282316..31283835,2	K562	blood:
10	chr15:31281186..31283904-chr15:31357047..31359370,2	MCF-7	breast:
11	chr15:31194465..31197297-chr15:31282167..31285499,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000134160	Chromatin interaction
ENSG00000207702	Chromatin interaction
ENSG00000259720	Chromatin interaction
ENSG00000226471	Chromatin interaction
ENSG00000176390	Chromatin interaction
ENSG00000118515	Chromatin interaction
ENSG00000198690	Chromatin interaction
ENSG00000100219	Chromatin interaction

Extended variants
information (count: 104 )
Associated
traits (count: 2 )

rSNPs within LD-proxies of this variant (count:90)

rs_ID	r²[population]
rs10163148	1.00[CHB][hapmap];0.94[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap]
rs10519726	0.83[CHB][hapmap];0.88[CHD][hapmap]
rs11070678	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs11070718	0.92[CHB][hapmap];0.89[CHD][hapmap];0.82[ASN][1000 genomes]
rs1133642	0.91[CHB][hapmap];0.89[CHD][hapmap];0.82[ASN][1000 genomes]
rs11638295	0.92[CHB][hapmap];0.89[CHD][hapmap]
rs12437580	0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs12439664	0.82[ASN][1000 genomes]
rs12441318	0.85[CHB][hapmap]
rs12442333	0.82[CHB][hapmap]
rs12443369	0.89[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs12901022	0.92[CHB][hapmap];0.89[CHD][hapmap]
rs12906480	0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs12913397	0.82[ASN][1000 genomes]
rs12914207	0.90[ASN][1000 genomes]
rs12914438	0.82[ASN][1000 genomes]
rs1404467	0.81[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs1404468	0.92[CHB][hapmap]
rs1404469	0.92[CHB][hapmap];0.89[CHD][hapmap];0.82[ASN][1000 genomes]
rs1404470	0.82[ASN][1000 genomes]
rs1425291	0.82[ASN][1000 genomes]
rs1474381	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs1474382	1.00[CHB][hapmap];0.94[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap]
rs1524876	0.92[CHB][hapmap];0.89[CHD][hapmap];0.82[ASN][1000 genomes]
rs16956341	0.83[CHB][hapmap]
rs16956362	0.83[CHB][hapmap];0.88[CHD][hapmap]
rs16956366	0.83[CHB][hapmap]
rs16956414	0.83[CHB][hapmap];0.87[CHD][hapmap]
rs16956422	0.83[CHB][hapmap];0.82[CHD][hapmap]
rs17815804	0.88[CHD][hapmap]
rs1880499	0.92[CHB][hapmap];0.82[ASN][1000 genomes]
rs2042613	0.92[CHB][hapmap];0.83[CHD][hapmap]
rs2113945	1.00[CHB][hapmap];0.94[CHD][hapmap]
rs2113946	0.92[CHB][hapmap];0.89[CHD][hapmap]
rs2140735	0.86[AMR][1000 genomes];0.94[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs2272218	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2272219	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2293319	0.95[CEU][hapmap];1.00[CHB][hapmap];0.94[CHD][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.97[TSI][hapmap];0.84[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs2293320	0.88[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.89[LWK][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.84[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs2339048	0.84[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs28564430	0.85[ASN][1000 genomes]
rs28693590	1.00[CHB][hapmap];0.94[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap]
rs2873	0.92[CHB][hapmap]
rs2949568	0.82[GIH][hapmap];0.91[TSI][hapmap]
rs2949569	0.92[CHB][hapmap];0.84[CHD][hapmap]
rs2949570	0.92[CHB][hapmap]
rs2949572	0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs2949573	0.92[CHB][hapmap];0.89[CHD][hapmap]
rs2949575	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2949576	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.98[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2949577	0.92[CHB][hapmap];0.82[ASN][1000 genomes]
rs2949578	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs2955783	0.92[CHB][hapmap];0.82[ASN][1000 genomes]
rs2955787	0.81[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2955790	0.92[CHB][hapmap];0.89[CHD][hapmap]
rs2955791	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.94[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs2955796	0.85[CHB][hapmap]
rs2959039	0.85[CHB][hapmap]
rs2959047	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2959049	1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[ASN][1000 genomes]
rs2959050	0.91[AFR][1000 genomes];0.94[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2959051	0.85[AFR][1000 genomes];0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs3743233	0.85[ASN][1000 genomes]
rs3784588	0.83[CHB][hapmap];0.88[CHD][hapmap]
rs4344701	0.83[ASN][1000 genomes]
rs4779796	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs4779797	1.00[CHB][hapmap];0.94[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap]
rs6493358	0.83[CHB][hapmap]
rs71474640	0.87[AFR][1000 genomes];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs7161812	1.00[CHB][hapmap]
rs7164530	0.82[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs7164939	0.83[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes]
rs7165798	0.92[CHB][hapmap]
rs7169064	1.00[CHB][hapmap];0.94[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap]
rs7170710	0.92[CHB][hapmap];0.82[ASN][1000 genomes]
rs7170772	0.82[AFR][1000 genomes];0.99[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs7175256	0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs7175951	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs7176351	1.00[CHB][hapmap];0.94[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap]
rs7178375	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs7178533	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs7182143	0.92[CHB][hapmap]
rs7183880	0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs798101	0.85[CHB][hapmap]
rs8040989	0.92[CHB][hapmap];0.83[ASN][1000 genomes]
rs8041717	1.00[CHB][hapmap];1.00[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.93[TSI][hapmap];0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs871312	0.83[CHB][hapmap];0.88[CHD][hapmap]
rs872843	0.83[CHB][hapmap]
rs964925	0.84[CHD][hapmap]
rs9806159	1.00[CHB][hapmap];0.94[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:14 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531138	chr15:30653877-31609679	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	96 gene(s)	inside rSNPs	diseases
2	nsv916936	chr15:30921917-31337510	Active TSS Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
3	nsv525795	chr15:30936285-31324531	Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
4	nsv903831	chr15:30986051-31723279	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
5	nsv1046874	chr15:31008133-31294654	Enhancers Strong transcription Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
6	nsv1054147	chr15:31014507-31972706	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
7	nsv542306	chr15:31014507-31972706	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
8	nsv832951	chr15:31131239-31304469	Strong transcription Active TSS Enhancers Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
9	nsv1036018	chr15:31140415-31544888	Enhancers Flanking Active TSS Active TSS Genic enhancers Strong transcription Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	58 gene(s)	inside rSNPs	diseases
10	nsv903834	chr15:31179534-31293774	Weak transcription Genic enhancers Enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
11	esv33507	chr15:31183324-31471023	Weak transcription Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
12	nsv832952	chr15:31204426-31333998	Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
13	nsv1052722	chr15:31261834-31609680	Flanking Active TSS Weak transcription Enhancers Active TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
14	nsv542315	chr15:31261834-31609680	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases

mRNA abundance (count:2)

SNP	Gene	Cis/trans	Tissue	Source
rs3743231	RP11-932O9.7	cis	Muscle Skeletal	GTEx
rs3743231	SNORD115-35	cis	parietal	SCAN

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:31278200-31283200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr15:31280800-31284400	Active TSS	Placenta	Placenta
3	chr15:31282000-31283200	Flanking Active TSS	Primary B cells from cord blood	blood
4	chr15:31282000-31283200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr15:31282000-31283800	Active TSS	Right Atrium	heart
6	chr15:31282000-31284600	Active TSS	Esophagus	oesophagus
7	chr15:31282000-31284800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr15:31282200-31283200	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
9	chr15:31282200-31283200	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
10	chr15:31282200-31283400	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr15:31282200-31283400	Flanking Active TSS	Primary hematopoietic stem cells	blood
12	chr15:31282200-31283400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr15:31282200-31284400	Active TSS	HUES6 Cell Line	embryonic stem cell
14	chr15:31282200-31284800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr15:31282200-31284800	Active TSS	HMEC	breast
16	chr15:31282200-31285000	Active TSS	HSMM	muscle
17	chr15:31282400-31283200	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
18	chr15:31282400-31283200	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
19	chr15:31282400-31283200	Flanking Active TSS	Fetal Heart	heart
20	chr15:31282400-31283400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr15:31282400-31283400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr15:31282400-31283400	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
23	chr15:31282400-31283600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
24	chr15:31282400-31284200	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr15:31282400-31284200	Active TSS	Fetal Muscle Trunk	muscle
26	chr15:31282400-31284400	Active TSS	HUES48 Cell Line	embryonic stem cell
27	chr15:31282400-31284600	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
28	chr15:31282400-31284600	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
29	chr15:31282400-31284600	Active TSS	Muscle Satellite Cultured Cells	--
30	chr15:31282400-31284800	Active TSS	ES-I3 Cell Line	embryonic stem cell
31	chr15:31282400-31284800	Active TSS	H1 Cell Line	embryonic stem cell
32	chr15:31282400-31284800	Active TSS	Colonic Mucosa	Colon
33	chr15:31282400-31284800	Active TSS	HSMMtube	muscle
34	chr15:31282400-31284800	Active TSS	NHLF	lung
35	chr15:31282400-31285000	Active TSS	H9 Cell Line	embryonic stem cell
36	chr15:31282400-31285000	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr15:31282600-31283200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr15:31282600-31283200	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
39	chr15:31282600-31283200	Weak transcription	Spleen	Spleen
40	chr15:31282600-31283400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
41	chr15:31282600-31283400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
42	chr15:31282600-31284200	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
43	chr15:31282600-31284200	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr15:31282600-31284200	Active TSS	Fetal Thymus	thymus
45	chr15:31282600-31284400	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr15:31282600-31284400	Active TSS	Breast Myoepithelial Primary Cells	Breast
47	chr15:31282600-31284400	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
48	chr15:31282600-31284400	Active TSS	Primary monocytes fromperipheralblood	blood
49	chr15:31282600-31284400	Active TSS	Primary B cells from peripheral blood	blood
50	chr15:31282600-31284400	Active TSS	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links